nab-Paclitaxel in Combination with Carboplatin for a Previously Treated Thymic Carcinoma

Publisher： Karger

E-ISSN： 1662-6575|7|1|14-17

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.7, Iss.1, 2014-01, pp. : 14-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

First-Line Treatment with Carboplatin plus nab-Paclitaxel and Maintenance Monotherapy with nab-Paclitaxel for a Thymic Carcinoma: A Case Report

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-06 ,pp. : 571-576

Karger

Access to resources Recommend Favorite

Weekly Paclitaxel and Carboplatin Combination Chemotherapy in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck

By  

Oncology Research and Treatment, Vol. 26, Iss. 6, 2004-01 ,pp. : 568-572

Karger

Access to resources Recommend Favorite

Phase II Trial of a Paclitaxel-Carboplatin Combination in Recurrent Squamous Cell Carcinoma of the Head and Neck

By  

Oncology, Vol. 60, Iss. 1, 2000-12 ,pp. : 66-71

Karger

Access to resources Recommend Favorite

Case of pure ovarian squamous cell carcinoma resistant to combination chemotherapy with paclitaxel and carboplatin but responsive to monotherapy with weekly irinotecan

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 5, 2015-05 ,pp. : 809-812

John Wiley & Sons Inc

Access to resources Recommend Favorite

Carcinoma of Unknown Primary Site Treated with Carboplatin + Paclitaxel + Bevacizumab + Erlotinib and Its Maintenance Chemotherapy

By  

Case Reports in Oncology, Vol. 7, Iss. 2, 2014-08 ,pp. : 583-590

Karger

Access to resources Recommend Favorite